A nine-year retrospective study on
fungemia in patients with
leukemia was conducted. A total of 79 episodes of
fungemia in 77 patients with
leukemia were documented. Candida parapsilosis
fungemia was associated more frequently with the presence of a central venous line and to the use of
parenteral nutrition than the other fungal species (p = 0.00026 and p = 0.01, respectively). The same fungus was isolated from both blood and surveillance cultures in 95% of Candida albicans and in 89% of Candida tropicalis
fungemia (p < 0.01 and p = 0.02, respectively). The
neutropenia and fungus colonization that resulted was associated significantly with the presence of invasive disease (p = 0.0024 and p = 0.0028, respectively). Conversely, central venous catheterization and
parenteral nutrition appeared to be associated with episodes without deep tissue invasion (p = 0.000037 and p = 0.001, respectively). Invasive mycosis due to the fungus isolated from blood was documented in 51 patients with a mortality rate of 69%, whereas in 20 patients without invasive mycosis, mortality rate was 21% (p = 0.000059). In patients with
fungemia, related or unrelated to the presence of a
central venous catheter, mortality was 24% and 64%, respectively (p = 0.00042). Mortality was highest with C. tropicalis (p = 0.0017) and lowest with C. parapsilosis (p = 0.057). Severe
neutropenia (polymorphonuclears < 100/mmc) appeared associated with a higher mortality rate (p = 0.012), whereas the recovery of
neutropenia was related adversely to a fatal outcome (p < 0.01). With antifungal
therapy, there was no statistically significant difference whether antifungal
therapy was given or not.(ABSTRACT TRUNCATED AT 250 WORDS)